EXC
EXC
US30161N1019
Exelon Corporation
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.4x
Defensive
Volatility (5Y p.a.)
21.0% p.a.
5-Year Horizon
Max Drawdown (5Y)
-33.1%
5-Year Horizon
Sharpe Ratio
0.07
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -10.5%
3 Years 19.9% -20.1% 0 +2.5%
5 Years 21.0% -33.1% 0.07 +3.9%
10 Years 24.0% -41.2% 0.15 +6.1%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
2 ISS Score: 2 / 10
Audit Risk
3 ISS Score: 3 / 10
Board Risk
1 ISS Score: 1 / 10
Short Ratio
4.78
ende